Astrazeneca Plc (AZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AZN.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 22 | $77.12 | $42.06 | $62.21 | $54.1 | 14.99% |
The Trend in the Analyst Price Target
Over the past 101 days, AZN's average price target has gone up $3.66.
AZN reports an average of 7.17% for its upside potential over the past 174 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-11-29 | 22 | 77.12 | 42.06 | 62.21 | 52.61 | 18.25% |
| 2020-11-26 | 22 | 77.12 | 42.06 | 62.02 | 52.60 | 17.91% |
| 2020-11-19 | 22 | 77.12 | 42.06 | 61.70 | 54.03 | 14.2% |
| 2020-11-14 | 22 | 77.12 | 42.06 | 61.59 | 57.38 | 7.34% |
| 2020-10-28 | 22 | 77.12 | 40.72 | 60.75 | 50.98 | 19.16% |
| 2020-09-30 | 22 | 77.12 | 41.22 | 60.62 | 54.80 | 10.62% |
| 2020-09-23 | 21 | 77.12 | 41.22 | 60.39 | 55.66 | 8.5% |
| 2020-09-17 | 21 | 77.12 | 41.22 | 59.65 | 55.94 | 6.63% |
| 2020-09-02 | 21 | 68.47 | 41.22 | 59.29 | 55.90 | 6.06% |
| 2020-08-27 | 21 | 68.47 | 41.22 | 58.56 | 56.11 | 4.37% |
| 2020-08-20 | 21 | 68.47 | 41.22 | 58.55 | 56.49 | 3.65% |
| 2020-08-12 | 21 | 68.47 | 41.22 | 58.40 | 56.74 | 2.93% |
| 2020-08-05 | 21 | 68.47 | 41.09 | 58.38 | 55.95 | 4.34% |
| 2020-07-25 | 21 | 65.34 | 37.87 | 55.93 | 55.80 | 0.23% |
| 2020-07-16 | 21 | 65.34 | 37.87 | 55.92 | 57.43 | -2.63% |
| 2020-07-09 | 20 | 65.34 | 36.60 | 55.36 | 53.97 | 2.58% |
| 2020-07-01 | 20 | 65.34 | 36.60 | 55.26 | 53.32 | 3.64% |
| 2020-06-25 | 20 | 65.00 | 36.60 | 55.14 | 53.01 | 4.02% |
| 2020-06-18 | 21 | 65.00 | 36.60 | 55.67 | 52.66 | 5.72% |
| 2020-06-11 | 21 | 65.00 | 36.60 | 55.58 | 51.57 | 7.78% |
| 2020-06-08 | 21 | 65.00 | 36.60 | 55.35 | 52.58 | 5.27% |
AZN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The Trend in the Broker Recommendations
AZN's average broker recommendation rating improved by 0.12 over the prior 61 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- AZN has a greater number of analysts covering the stock than 95.47% of all US stocks.
- Astrazeneca Plc's upside potential (average analyst target price relative to current price) is greater than 10.64% of Pharmaceutical Products stocks.
- Astrazeneca Plc's average analyst price target is higher than 83.24% of Pharmaceutical Products stocks.
- AZN has a less variance in analysts' estimates than 20.14% of all US stocks.
Is AZN a Buy, Hold or Sell? See the POWR Ratings now!